Geron Corp (GERN)

Geron (GERN) Stock Price & Analysis


GERN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.18 - $3.84
Previous Close$2.14
Average Volume (3M)9.17M
Market Cap
Enterprise Value$971.67M
Total Cash (Recent Filing)$172.75M
Total Debt (Recent Filing)$55.75M
Price to Earnings (P/E)-5.8
May 08, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding508,722,486
10 Day Avg. Volume6,962,158
30 Day Avg. Volume9,174,539
Standard Deviation0.23
Financial Highlights & Ratios
Price to Book (P/B)14.82
Price to Sales (P/S)1852.23
Price to Cash Flow (P/CF)41.10
P/FCF Ratio-9.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.63K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.24
Price Target Upside130.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Geron Corp’s price range in the past 12 months?
Geron Corp lowest stock price was $1.18 and its highest was $3.84 in the past 12 months.
    What is Geron Corp’s market cap?
    Currently, no data Available
    When is Geron Corp’s upcoming earnings report date?
    Geron Corp’s upcoming earnings report date is May 08, 2023 which is in 37 days.
      How were Geron Corp’s earnings last quarter?
      Geron Corp released its earnings results on Mar 16, 2023. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.123 by $0.023.
        Is Geron Corp overvalued?
        According to Wall Street analysts Geron Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Geron Corp pay dividends?
          Geron Corp pays a Notavailable dividend of $0.15 which represents an annual dividend yield of N/A. See more information on Geron Corp dividends here
            What is Geron Corp’s EPS estimate?
            Geron Corp’s EPS estimate is -$0.1.
              How many shares outstanding does Geron Corp have?
              Geron Corp has 508,722,470 shares outstanding.
                What happened to Geron Corp’s price movement after its last earnings report?
                Geron Corp reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.123. Following the earnings report the stock price went down -4.528%.
                  Which hedge fund is a major shareholder of Geron Corp?
                  Among the largest hedge funds holding Geron Corp’s share is RA Capital Management. It holds Geron Corp’s shares valued at 31M.


                    Geron Stock Smart Score

                    The Geron stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Geron Corp

                    Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.


                    Top 5 ETFs holding GERN

                    Currently, no data available
                    Please return soon. This page is being updated.
                    Up to five ETFs with an Outperform Smart Score that hold GERN. The ETFs are listed according to market value of GERN within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Iovance Biotherapeutics
                    Crinetics Pharmaceuticals
                    Viridian Therapeutics
                    Avid Bioservices

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis